Kontigo Care AB (publ) (KONT.ST)
SEK 2.64
(-1.49%)
SEK 2.64
(-1.49%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.67 Million SEK | -82.02% |
| 2022 | 4.13 Million SEK | 155.71% |
| 2021 | 2.66 Million SEK | 21.29% |
| 2020 | 2.19 Million SEK | 79.22% |
| 2019 | -945 Thousand SEK | 132.2% |
| 2018 | -4.07 Million SEK | 66.99% |
| 2017 | -11.61 Million SEK | 33.21% |
| 2016 | -17.27 Million SEK | -21.35% |
| 2015 | -14.23 Million SEK | -1095.93% |
| 2014 | -1.19 Million SEK | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 1.09 Million SEK | 95.19% |
| 2024 Q2 | 1.34 Million SEK | 23.2% |
| 2023 Q3 | 2.58 Million SEK | 285.82% |
| 2023 Q4 | 314 Thousand SEK | -87.85% |
| 2023 FY | - SEK | -82.02% |
| 2023 Q1 | 556 Thousand SEK | -53.67% |
| 2023 Q2 | 670 Thousand SEK | 20.5% |
| 2022 Q3 | 2.33 Million SEK | 8.35% |
| 2022 FY | - SEK | 155.71% |
| 2022 Q2 | 2.15 Million SEK | 91.05% |
| 2022 Q1 | 1.12 Million SEK | 106.09% |
| 2022 Q4 | 1.2 Million SEK | -48.61% |
| 2021 Q3 | 1.31 Million SEK | 293.41% |
| 2021 FY | - SEK | 21.29% |
| 2021 Q1 | 473 Thousand SEK | -51.1% |
| 2021 Q2 | 334 Thousand SEK | -29.39% |
| 2021 Q4 | 547.32 Thousand SEK | -58.35% |
| 2020 Q4 | 967.32 Thousand SEK | -4.88% |
| 2020 Q3 | 1.01 Million SEK | 377.46% |
| 2020 FY | - SEK | 79.22% |
| 2020 Q2 | 213 Thousand SEK | 21200.0% |
| 2020 Q1 | 1000.00 SEK | -99.87% |
| 2019 FY | - SEK | 132.2% |
| 2019 Q3 | 707 Thousand SEK | 1155.22% |
| 2019 Q4 | 787.85 Thousand SEK | 11.44% |
| 2019 Q2 | -67 Thousand SEK | 74.43% |
| 2019 Q1 | -262 Thousand SEK | 70.17% |
| 2018 Q4 | -878.35 Thousand SEK | -369.71% |
| 2018 Q3 | -187 Thousand SEK | 86.6% |
| 2018 Q1 | -1.61 Million SEK | 42.88% |
| 2018 Q2 | -1.39 Million SEK | 13.45% |
| 2018 FY | - SEK | 66.99% |
| 2017 Q2 | -3.83 Million SEK | -8.6% |
| 2017 FY | - SEK | 33.21% |
| 2017 Q4 | -2.82 Million SEK | -98.86% |
| 2017 Q1 | -3.53 Million SEK | 15.0% |
| 2017 Q3 | -1.42 Million SEK | 63.0% |
| 2016 Q1 | -4.42 Million SEK | -103.61% |
| 2016 Q4 | -4.15 Million SEK | -29.4% |
| 2016 Q2 | -5.47 Million SEK | -23.68% |
| 2016 FY | - SEK | -21.35% |
| 2016 Q3 | -3.21 Million SEK | 41.35% |
| 2015 FY | - SEK | -1095.93% |
| 2015 Q4 | -2.17 Million SEK | 30.59% |
| 2015 Q1 | -3.79 Million SEK | -1290.53% |
| 2015 Q2 | -5.14 Million SEK | -35.62% |
| 2015 Q3 | -3.13 Million SEK | 39.03% |
| 2014 Q4 | -272.55 Thousand SEK | 44.83% |
| 2014 Q1 | - SEK | 0.0% |
| 2014 FY | - SEK | 0.0% |
| 2014 Q3 | -494 Thousand SEK | -25.7% |
| 2014 Q2 | -393 Thousand SEK | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aino Health AB (publ) | -7.52 Million SEK | 122.287% |
| Bonzun AB (publ) | -28.58 Million SEK | 105.87% |
| Medhelp Care Aktiebolag (publ) | 10 Million SEK | 83.223% |
| RaySearch Laboratories AB (publ) | 405.93 Million SEK | 99.587% |
| Surgical Science Sweden AB (publ) | 246.9 Million SEK | 99.32% |